
### [MONDO:0002656](http://purl.obolibrary.org/obo/MONDO_0002656)
**Label:** skin carcinoma

**Subclasses:** [MONDO:0016287](http://purl.obolibrary.org/obo/MONDO_0016287) (adenoid basal carcinoma of the cervix uteri), [MONDO:0001702](http://purl.obolibrary.org/obo/MONDO_0001702) (labia majora carcinoma), [MONDO:0002956](http://purl.obolibrary.org/obo/MONDO_0002956) (skin cystic basal cell carcinoma), [MONDO:0002955](http://purl.obolibrary.org/obo/MONDO_0002955) (vulva basal cell carcinoma), [MONDO:0002958](http://purl.obolibrary.org/obo/MONDO_0002958) (signet ring basal cell carcinoma), [MONDO:0002957](http://purl.obolibrary.org/obo/MONDO_0002957) (sarcomatoid basal cell carcinoma), [MONDO:0002952](http://purl.obolibrary.org/obo/MONDO_0002952) (follicular basal cell carcinoma), [MONDO:0002951](http://purl.obolibrary.org/obo/MONDO_0002951) (skin adenoid basal cell carcinoma), [MONDO:0004337](http://purl.obolibrary.org/obo/MONDO_0004337) (perianal skin Paget's disease), [MONDO:0003207](http://purl.obolibrary.org/obo/MONDO_0003207) (eccrine adenocarcinoma), [MONDO:0002954](http://purl.obolibrary.org/obo/MONDO_0002954) (superficial basal cell carcinoma), [MONDO:0002953](http://purl.obolibrary.org/obo/MONDO_0002953) (skin infiltrative basal cell carcinoma), [MONDO:0004412](http://purl.obolibrary.org/obo/MONDO_0004412) (malignant spiradenoma), [MONDO:0002950](http://purl.obolibrary.org/obo/MONDO_0002950) (skin clear cell basal cell carcinoma), [MONDO:0003880](http://purl.obolibrary.org/obo/MONDO_0003880) (ceruminous carcinoma), [MONDO:0003881](http://purl.obolibrary.org/obo/MONDO_0003881) (vulvar apocrine adenocarcinoma), [MONDO:0005341](http://purl.obolibrary.org/obo/MONDO_0005341) (skin basal cell carcinoma), [MONDO:0011556](http://purl.obolibrary.org/obo/MONDO_0011556) (BCC1), [MONDO:0004091](http://purl.obolibrary.org/obo/MONDO_0004091) (basaloid squamous cell skin carcinoma), [MONDO:0003934](http://purl.obolibrary.org/obo/MONDO_0003934) (breast apocrine carcinoma), [MONDO:0002529](http://purl.obolibrary.org/obo/MONDO_0002529) (skin squamous cell carcinoma), [MONDO:0021588](http://purl.obolibrary.org/obo/MONDO_0021588) (eyelid sebaceous gland carcinoma), [MONDO:0002765](http://purl.obolibrary.org/obo/MONDO_0002765) (plantar verrucous skin carcinoma), [MONDO:0004469](http://purl.obolibrary.org/obo/MONDO_0004469) (pseudovascular skin squamous cell carcinoma), [MONDO:0003414](http://purl.obolibrary.org/obo/MONDO_0003414) (skin pilomatrix carcinoma), [MONDO:0006327](http://purl.obolibrary.org/obo/MONDO_0006327) (ocular sebaceous carcinoma), [MONDO:0003499](http://purl.obolibrary.org/obo/MONDO_0003499) (sarcomatoid squamous cell skin carcinoma), [MONDO:0006402](http://purl.obolibrary.org/obo/MONDO_0006402) (salivary gland basal cell adenocarcinoma), [MONDO:0003530](http://purl.obolibrary.org/obo/MONDO_0003530) (aggressive digital papillary adenocarcinoma), [MONDO:0003214](http://purl.obolibrary.org/obo/MONDO_0003214) (apocrine adenocarcinoma), [MONDO:0006962](http://purl.obolibrary.org/obo/MONDO_0006962) (sebaceous adenocarcinoma), [MONDO:0003531](http://purl.obolibrary.org/obo/MONDO_0003531) (eccrine papillary adenocarcinoma), [MONDO:0001470](http://purl.obolibrary.org/obo/MONDO_0001470) (anal margin squamous cell carcinoma), [MONDO:0006245](http://purl.obolibrary.org/obo/MONDO_0006245) (hidradenocarcinoma), [MONDO:0004420](http://purl.obolibrary.org/obo/MONDO_0004420) (breast malignant eccrine spiradenoma), [MONDO:0011465](http://purl.obolibrary.org/obo/MONDO_0011465) (infundibulocystic basal cell carcinoma), [MONDO:0003091](http://purl.obolibrary.org/obo/MONDO_0003091) (cutaneous mucoepidermoid carcinoma), [MONDO:0002938](http://purl.obolibrary.org/obo/MONDO_0002938) (metatypical basal cell carcinoma), [MONDO:0002937](http://purl.obolibrary.org/obo/MONDO_0002937) (nodular basal cell carcinoma), [MONDO:0002939](http://purl.obolibrary.org/obo/MONDO_0002939) (skin pigmented basal cell carcinoma), [MONDO:0019210](http://purl.obolibrary.org/obo/MONDO_0019210) (cutaneous neuroendocrine carcinoma), [MONDO:0001602](http://purl.obolibrary.org/obo/MONDO_0001602) (labia minora carcinoma), [MONDO:0002936](http://purl.obolibrary.org/obo/MONDO_0002936) (scrotum basal cell carcinoma), [MONDO:0002935](http://purl.obolibrary.org/obo/MONDO_0002935) (penis basal cell carcinoma), [MONDO:0002655](http://purl.obolibrary.org/obo/MONDO_0002655) (cutaneous Paget's disease), [MONDO:0004316](http://purl.obolibrary.org/obo/MONDO_0004316) (acantholytic squamous cell skin carcinoma), [MONDO:0005524](http://purl.obolibrary.org/obo/MONDO_0005524) (sweat gland carcinoma), [MONDO:0006973](http://purl.obolibrary.org/obo/MONDO_0006973) (skin appendage carcinoma), [MONDO:0003264](http://purl.obolibrary.org/obo/MONDO_0003264) (basosquamous carcinoma), [MONDO:0013876](http://purl.obolibrary.org/obo/MONDO_0013876) (basal cell carcinoma, susceptibility to, 7), [MONDO:0003180](http://purl.obolibrary.org/obo/MONDO_0003180) (cutaneous adenocystic carcinoma), [MONDO:0013101](http://purl.obolibrary.org/obo/MONDO_0013101) (BCC2), [MONDO:0013102](http://purl.obolibrary.org/obo/MONDO_0013102) (BCC3), [MONDO:0002949](http://purl.obolibrary.org/obo/MONDO_0002949) (morpheaform basal cell carcinoma), [MONDO:0002948](http://purl.obolibrary.org/obo/MONDO_0002948) (skin fibroepithelial basal cell carcinoma), [MONDO:0002945](http://purl.obolibrary.org/obo/MONDO_0002945) (micronodular basal cell carcinoma), [MONDO:0002947](http://purl.obolibrary.org/obo/MONDO_0002947) (adamantinoid basal cell epithelioma), [MONDO:0003635](http://purl.obolibrary.org/obo/MONDO_0003635) (sebaceous breast carcinoma), [MONDO:0002941](http://purl.obolibrary.org/obo/MONDO_0002941) (anal margin carcinoma), [MONDO:0002940](http://purl.obolibrary.org/obo/MONDO_0002940) (anal margin basal cell carcinoma), [MONDO:0002943](http://purl.obolibrary.org/obo/MONDO_0002943) (external ear basal cell carcinoma), [MONDO:0003876](http://purl.obolibrary.org/obo/MONDO_0003876) (eyelid carcinoma), [MONDO:0002942](http://purl.obolibrary.org/obo/MONDO_0002942) (sebaceous basal cell carcinoma), [MONDO:0004523](http://purl.obolibrary.org/obo/MONDO_0004523) (clear cell squamous cell skin carcinoma), [MONDO:0004641](http://purl.obolibrary.org/obo/MONDO_0004641) (skin carcinoma in situ), [MONDO:0006189](http://purl.obolibrary.org/obo/MONDO_0006189) (eccrine porocarcinoma), [MONDO:0004283](http://purl.obolibrary.org/obo/MONDO_0004283) (vulvar clear cell hidradenocarcinoma), [MONDO:0004083](http://purl.obolibrary.org/obo/MONDO_0004083) (Borst-Jadassohn intraepidermal carcinoma), [MONDO:0004281](http://purl.obolibrary.org/obo/MONDO_0004281) (vulvar eccrine porocarcinoma), [MONDO:0013104](http://purl.obolibrary.org/obo/MONDO_0013104) (BCC4), [MONDO:0013105](http://purl.obolibrary.org/obo/MONDO_0013105) (BCC5), [MONDO:0013106](http://purl.obolibrary.org/obo/MONDO_0013106) (BCC6), 

**Mapped go classes:** [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0021798](http://purl.obolibrary.org/obo/GO_0021798) (forebrain dorsal/ventral pattern formation), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0005628](http://purl.obolibrary.org/obo/GO_0005628) (prospore membrane), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0001709](http://purl.obolibrary.org/obo/GO_0001709) (cell fate determination), [GO:0031235](http://purl.obolibrary.org/obo/GO_0031235) (intrinsic component of the cytoplasmic side of the plasma membrane), [GO:0036120](http://purl.obolibrary.org/obo/GO_0036120) (cellular response to platelet-derived growth factor stimulus), [GO:0035270](http://purl.obolibrary.org/obo/GO_0035270) (endocrine system development), [GO:0021782](http://purl.obolibrary.org/obo/GO_0021782) (glial cell development), [GO:0044325](http://purl.obolibrary.org/obo/GO_0044325) (ion channel binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0001953](http://purl.obolibrary.org/obo/GO_0001953) (negative regulation of cell-matrix adhesion), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus), [GO:0001957](http://purl.obolibrary.org/obo/GO_0001957) (intramembranous ossification), [GO:0001839](http://purl.obolibrary.org/obo/GO_0001839) (neural plate morphogenesis), [GO:0035143](http://purl.obolibrary.org/obo/GO_0035143) (caudal fin morphogenesis), [GO:0021537](http://purl.obolibrary.org/obo/GO_0021537) (telencephalon development), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0021536](http://purl.obolibrary.org/obo/GO_0021536) (diencephalon development), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0031578](http://purl.obolibrary.org/obo/GO_0031578) (mitotic spindle orientation checkpoint), [GO:0019900](http://purl.obolibrary.org/obo/GO_0019900) (kinase binding), [GO:0007120](http://purl.obolibrary.org/obo/GO_0007120) (axial cellular bud site selection), [GO:0007121](http://purl.obolibrary.org/obo/GO_0007121) (bipolar cellular bud site selection), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0021522](http://purl.obolibrary.org/obo/GO_0021522) (spinal cord motor neuron differentiation), [GO:0021523](http://purl.obolibrary.org/obo/GO_0021523) (somatic motor neuron differentiation), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0021520](http://purl.obolibrary.org/obo/GO_0021520) (spinal cord motor neuron cell fate specification), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0030239](http://purl.obolibrary.org/obo/GO_0030239) (myofibril assembly), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0045606](http://purl.obolibrary.org/obo/GO_0045606) (positive regulation of epidermal cell differentiation), [GO:0008142](http://purl.obolibrary.org/obo/GO_0008142) (oxysterol binding), [GO:0042693](http://purl.obolibrary.org/obo/GO_0042693) (muscle cell fate commitment), [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis), [GO:0043422](http://purl.obolibrary.org/obo/GO_0043422) (protein kinase B binding), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0043547](http://purl.obolibrary.org/obo/GO_0043547) (positive regulation of GTPase activity), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0014033](http://purl.obolibrary.org/obo/GO_0014033) (neural crest cell differentiation), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0008158](http://purl.obolibrary.org/obo/GO_0008158) (hedgehog receptor activity), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0032474](http://purl.obolibrary.org/obo/GO_0032474) (otolith morphogenesis), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:0090630](http://purl.obolibrary.org/obo/GO_0090630) (activation of GTPase activity), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0003231](http://purl.obolibrary.org/obo/GO_0003231) (cardiac ventricle development), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0001726](http://purl.obolibrary.org/obo/GO_0001726) (ruffle), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development), [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development), [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development), [GO:0036267](http://purl.obolibrary.org/obo/GO_0036267) (invasive filamentous growth), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007162](http://purl.obolibrary.org/obo/GO_0007162) (negative regulation of cell adhesion), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0007163](http://purl.obolibrary.org/obo/GO_0007163) (establishment or maintenance of cell polarity), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0045879](http://purl.obolibrary.org/obo/GO_0045879) (negative regulation of smoothened signaling pathway), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0030833](http://purl.obolibrary.org/obo/GO_0030833) (regulation of actin filament polymerization), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0045880](http://purl.obolibrary.org/obo/GO_0045880) (positive regulation of smoothened signaling pathway), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0048635](http://purl.obolibrary.org/obo/GO_0048635) (negative regulation of muscle organ development), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0005113](http://purl.obolibrary.org/obo/GO_0005113) (patched binding), [GO:0009954](http://purl.obolibrary.org/obo/GO_0009954) (proximal/distal pattern formation), [GO:0001784](http://purl.obolibrary.org/obo/GO_0001784) (phosphotyrosine residue binding), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0005901](http://purl.obolibrary.org/obo/GO_0005901) (caveola), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development), [GO:0072175](http://purl.obolibrary.org/obo/GO_0072175) (epithelial tube formation), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0005119](http://purl.obolibrary.org/obo/GO_0005119) (smoothened binding), [GO:0009957](http://purl.obolibrary.org/obo/GO_0009957) (epidermal cell fate specification), [GO:0043087](http://purl.obolibrary.org/obo/GO_0043087) (regulation of GTPase activity), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0048663](http://purl.obolibrary.org/obo/GO_0048663) (neuron fate commitment), [GO:0051020](http://purl.obolibrary.org/obo/GO_0051020) (GTPase binding), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0097108](http://purl.obolibrary.org/obo/GO_0097108) (hedgehog family protein binding), [GO:0071679](http://purl.obolibrary.org/obo/GO_0071679) (commissural neuron axon guidance), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0060896](http://purl.obolibrary.org/obo/GO_0060896) (neural plate pattern specification), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0048795](http://purl.obolibrary.org/obo/GO_0048795) (swim bladder morphogenesis), [GO:0048794](http://purl.obolibrary.org/obo/GO_0048794) (swim bladder development), [GO:0010002](http://purl.obolibrary.org/obo/GO_0010002) (cardioblast differentiation), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:0060042](http://purl.obolibrary.org/obo/GO_0060042) (retina morphogenesis in camera-type eye), [GO:0060844](http://purl.obolibrary.org/obo/GO_0060844) (arterial endothelial cell fate commitment), [GO:0008544](http://purl.obolibrary.org/obo/GO_0008544) (epidermis development), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0055002](http://purl.obolibrary.org/obo/GO_0055002) (striated muscle cell development), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0035912](http://purl.obolibrary.org/obo/GO_0035912) (dorsal aorta morphogenesis), [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0035479](http://purl.obolibrary.org/obo/GO_0035479) (angioblast cell migration from lateral mesoderm to midline), [GO:0021508](http://purl.obolibrary.org/obo/GO_0021508) (floor plate formation), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0009880](http://purl.obolibrary.org/obo/GO_0009880) (embryonic pattern specification), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0021984](http://purl.obolibrary.org/obo/GO_0021984) (adenohypophysis development), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0060956](http://purl.obolibrary.org/obo/GO_0060956) (endocardial cell differentiation), [GO:0060830](http://purl.obolibrary.org/obo/GO_0060830) (ciliary receptor clustering involved in smoothened signaling pathway), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0042633](http://purl.obolibrary.org/obo/GO_0042633) (hair cycle), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0030447](http://purl.obolibrary.org/obo/GO_0030447) (filamentous growth), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0048741](http://purl.obolibrary.org/obo/GO_0048741) (skeletal muscle fiber development), [GO:0005929](http://purl.obolibrary.org/obo/GO_0005929) (cilium), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0046326](http://purl.obolibrary.org/obo/GO_0046326) (positive regulation of glucose import), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0000131](http://purl.obolibrary.org/obo/GO_0000131) (incipient cellular bud site), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0005935](http://purl.obolibrary.org/obo/GO_0005935) (cellular bud neck), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), 

**Class expressions from DL-Learner:**

- Thing 55.61%
- [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) 51.30%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) 51.30%
- [GO:0007114](http://purl.obolibrary.org/obo/GO_0007114) (cell budding) 51.30%
- [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) and [GO:1903047](http://purl.obolibrary.org/obo/GO_1903047) (mitotic cell cycle process) 51.30%
- [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) and [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division) 51.30%
- [GO:0030010](http://purl.obolibrary.org/obo/GO_0030010) (establishment of cell polarity) and [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) 51.30%
- [GO:0022402](http://purl.obolibrary.org/obo/GO_0022402) (cell cycle process) and [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) 51.30%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) and [GO:1903047](http://purl.obolibrary.org/obo/GO_1903047) (mitotic cell cycle process) 51.30%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) and [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division) 51.30%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) and [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) 51.30%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) and [GO:0030010](http://purl.obolibrary.org/obo/GO_0030010) (establishment of cell polarity) 51.30%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) and [GO:0022402](http://purl.obolibrary.org/obo/GO_0022402) (cell cycle process) 51.30%
- [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process) and [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) 51.30%
- [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process) and [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) 51.30%


